Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 369,561 | 356,999 | 304,806 | 288,818 | 364,523 |
| Cost of Goods | 35,837 | 40,774 | 33,996 | 35,663 | 38,777 |
| Gross Profit | 333,724 | 316,225 | 270,810 | 253,155 | 325,746 |
| Operating Expenses | 226,798 | 237,119 | 225,452 | 217,035 | 217,555 |
| Operating Income | 107,763 | 79,880 | 46,354 | 36,783 | 108,968 |
| Other Income | 12,487 | 6,171 | 13,380 | 13,381 | 12,780 |
| Pre-tax Income | 120,250 | 86,051 | 59,734 | 50,164 | 121,748 |
| Income Tax | 28,024 | 17,981 | 868 | 10,509 | 23,534 |
| Net Income Continuous | 92,226 | 68,070 | 58,866 | 39,655 | 98,214 |
| Minority Interests | 433 | 248 | 296 | 1,211 | 384 |
| Net Income | $91,793 | $67,822 | $58,570 | $38,444 | $97,830 |
| EPS Basic Total Ops | 0.95 | 0.71 | 0.62 | 0.40 | 1.02 |
| EPS Basic Continuous Ops | 0.96 | 0.71 | 0.62 | 0.41 | 1.03 |
| EPS Diluted Total Ops | 0.94 | 0.70 | 0.59 | 0.40 | 1.01 |
| EPS Diluted Continuous Ops | 0.95 | 0.70 | 0.60 | 0.41 | 1.01 |
| EPS Diluted Before Non-Recurring Items | 1.09 | 0.84 | 0.57 | N/A | N/A |
| EBITDA(a) | $132,190 | $105,077 | $70,404 | $57,161 | $128,883 |